| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 32 | 4,665,510 | TEVA, CVNA, MOH, PSKY | 13F-HR | 7/29/2026 | 000117266126002907 |
| Q1 2026 | 35 | 5,064,156 | TEVA, CVNA, PSKY, VAL | 13F-HR | 5/14/2026 | 000117266126001922 |
| Q4 2025 | 39 | 5,738,292 | CVNA, TEVA, PSKY, SBSW | 13F-HR | 2/10/2026 | 000117266126000570 |
| Q3 2025 | 36 | 5,411,143 | CVNA, PSKY, TEVA, VEON | NEW HOLDINGS | 11/13/2025 | 000117266125004755 |
| Q3 2025 | 35 | 5,411,143 | CVNA, PSKY, TEVA, VEON | 13F-HR | 11/12/2025 | 000117266125004702 |
| Q2 2025 | 45 | 4,704,514 | CVNA, PARA, TEVA, RRC | 13F-HR | 8/13/2025 | 000117266125003216 |
| Q1 2025 | 45 | 3,828,596 | CVNA, PARA, TEVA, HMY | 13F-HR | 5/15/2025 | 000117266125002046 |
| Q4 2024 | 53 | 3,727,561 | CVNA, TEVA, PARA, RRC | 13F-HR | 2/4/2025 | 000117266125000491 |
| Q3 2024 | 46 | 3,468,084 | CVNA, TEVA, PARA, HMY | 13F-HR | 11/13/2024 | 000117266124004632 |
| Q2 2024 | 50 | 2,976,475 | CVNA, TEVA, PARA, VAL | 13F-HR | 8/12/2024 | 000173276824000005 |
| Q1 2024 | 47 | 2,387,978 | TEVA, CVNA, VAL, RRC | 13F-HR | 5/15/2024 | 000173276824000003 |
| Q4 2023 | 34 | 2,077,573 | TEVA, CVNA, VAL, RRC | 13F-HR | 2/13/2024 | 000173276824000001 |
| Q3 2023 | 33 | 1,864,840 | TEVA, RRC, VAL, CVNA | 13F-HR | 11/13/2023 | 000173276823000007 |
| Q2 2023 | 33 | 1,547,548 | RRC, TEVA, SLB, CVNA | 13F-HR | 8/11/2023 | 000173276823000006 |
| Q1 2023 | 20 | 1,396,101 | RRC, TEVA, WFRD, SLB | 13F-HR | 5/15/2023 | 000173276823000005 |
| Q4 2022 | 18 | 1,332,542 | VEON, PARA, SLB, NG | 13F-HR | 2/15/2023 | 000173276823000002 |
| Q3 2022 | 16 | 1,085,792 | CCJ, WFRD, RRC, VAL | 13F-HR | 11/7/2022 | 000173276822000004 |
| Q2 2022 | 16 | 1,034,297 | CCJ, RRC, WFRD, SLB | 13F-HR | 8/12/2022 | 000173276822000003 |
| Q1 2022 | 16 | 1,525,849 | CCJ, RRC, WFRD, HMY | 13F-HR | 5/3/2022 | 000173276822000002 |
| Q4 2021 | 18 | 1,332,542 | VEON, PARA, SLB, NG | 13F-HR | 2/14/2023 | 000173276823000001 |
| Q4 2021 | 16 | 1,382,286 | CCJ, SLB, WFRD, RRC | 13F-HR | 1/18/2022 | 000173276822000001 |
| Q3 2021 | 14 | 1,268,565 | CCJ, RRC, SLB, VEON | 13F-HR | 11/1/2021 | 000173276821000005 |
| Q2 2021 | 13 | 1,154,704 | CCJ, SLB, VEON, RRC | 13F-HR | 7/29/2021 | 000173276821000004 |
| Q1 2021 | 9 | 872,292 | CCJ, SLB, VEON, RRC | 13F-HR | 4/29/2021 | 000173276821000003 |
| Q4 2020 | 11 | 827,376 | SLB, SBSW, CCJ, VEON | 13F-HR | 1/20/2021 | 000173276821000001 |
| Q3 2020 | 9 | 622,324 | SBSW, SLB, CCJ, NG | 13F-HR | 10/29/2020 | 000173276820000005 |
| Q2 2020 | 8 | 609,883 | SLB, SBSW, CCJ, VEON | 13F-HR | 7/22/2020 | 000173276820000004 |
| Q1 2020 | 8 | 340,214 | CCJ, SLB, SBGL, VEON | 13F-HR | 4/28/2020 | 000173276820000003 |
| Q4 2019 | 8 | 701,339 | SBGL, VEON, SLB, CCJ | 13F-HR | 1/22/2020 | 000173276820000002 |
| Q3 2019 | 6 | 509,806 | SBGL, VEON, CCJ, HMY | 13F-HR | 10/24/2019 | 000173276819000006 |
| Q2 2019 | 7 | 496,342 | SBGL, VEON, CCJ, NG | 13F-HR | 7/8/2019 | 000173276819000005 |
| Q1 2019 | 7 | 420,752 | SBGL, VEON, CCJ, HMY | 13F-HR | 5/9/2019 | 000173276819000004 |
| Q4 2018 | 7 | 351,426 | SBGL, VEON, CCJ, HMY | 13F-HR | 2/5/2019 | 000173276819000002 |
| Q3 2018 | 7 | 352,056 | SBGL, VEON, CCJ, HMY | 13F-HR | 10/5/2018 | 000173276818000006 |
| Q2 2018 | 7 | 329,510 | SBGL, VEON, CCJ, NG | 13F-HR | 7/23/2018 | 000173276818000005 |
| Q1 2018 | 7 | 290,357 | SBGL, VEON, CCJ, HMY | 13F-HR | 4/16/2018 | 000173276818000003 |
| Q4 2017 | 4 | 206,706 | SBGL, VEON, CCJ, HMY | 13F-HR | 3/14/2018 | 000173276818000002 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G.
5 securities where the latest filing since 12/18/2024 is a 13G, the newest filed 9/3/2026. View all